Announcements Trials
Browse Landscape

Phase

Phase 2 7Phase 1 2Phase 1/2 1

Status

Unknown 2Completed 2Terminated 1

Sponsor Class

INDUSTRY 2

Study Type

Interventional 2

Sponsor

Cancer Type

Other solid neoplasm 2

Conditions

Solid Tumor 1Advanced Solid Tumors 1

Interventions

Cyclophosphamide 51fludarabine 38Injections 32Gemcitabine 25Paclitaxel 24Cisplatin 22Radiotherapy 19toripalimab 18pembrolizumab 18Carboplatin 17Capecitabine 17Fluorouracil 15Oxaliplatin 14Nivolumab 14Docetaxel 12camrelizumab 11apatinib 11Temozolomide 11Immunotherapy, Adoptive 11Cetuximab 11Bevacizumab 10Irinotecan 9Drug Therapy 9sintilimab 8Etoposide 8aldesleukin 7Taxes 7Rituximab 7Radiosurgery 7Peripheral Blood Stem Cell Transplantation 7

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 1 × Unknown × tesetaxel × Clear all
NCT01315431 2012-07-24

A Study of Tesetaxel Plus Capecitabine in Patients With Solid Tumors

Genta Incorporated

Phase 1 Unknown
9 enrolled
Other solid neoplasm

Solid Tumor

NCT01337310 2012-03-13

Study of Tesetaxel in Japanese Patients With Solid Tumors

Genta Incorporated

Phase 1 Unknown
12 enrolled
Other solid neoplasm

Advanced Solid Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡